Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of LASP1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LASP1 mRNA | affects expression | 16483693
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in increased expression of LASP1 mRNA | increases expression | 15912405
|
C423222 |
cotylenin A |
cotylenin A results in increased expression of LASP1 mRNA | increases expression | 16129123
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LASP1 mRNA | affects cotreatment|increases expression | 17942748
|
D005472 |
Fluorouracil |
LASP1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of LASP1 mRNA | increases expression | 16221962
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA | affects cotreatment|increases expression | 17183730
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of LASP1 mRNA | increases expression | 16849584
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of LASP1 mRNA | decreases expression | 16807920
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LASP1 mRNA | decreases expression | 18445702
|
D012645 |
Selenomethionine |
Selenomethionine affects the expression of LASP1 mRNA | affects expression | 17222674
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of LASP1 mRNA | affects binding|decreases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LASP1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LASP1 mRNA | decreases expression | 18796159
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LASP1 mRNA | decreases expression | 18796159 15644576
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of LASP1 mRNA | increases expression | 16129123
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of LASP1 mRNA | affects expression | 21346803
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.43 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
14.43 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
14.43 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.93 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.34 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.34 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.62 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.69 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.69 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.57 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.21 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17376794 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18940202 17157402 18985861 18396377 18558336 19460635 15238991 19232924 17507914 17688650 20603192 18775368 18316065 16609825 18177632 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.41 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.08 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.30 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.30 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.30 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.03 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.03 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.86 | 19217205 18608205 15136595 18357371 16110121 16557594 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.86 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.61 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.19 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.62 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.62 | 17045692 16799960 16332177 17971768 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.62 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.02 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.73 | 16280240 16757204 18986760 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.73 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.70 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
7.70 | 15817613 14694615 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.61 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.71 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.75 | 15861022 16919318 17110522 16105132 11677210 17681005 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.75 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.19 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.77 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.77 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.72 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.23 | 17172411 16510598 16340194 15001691 17287894 17725105 17169374 17016597 18772588 17018589 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 17695437 16524972 17255274 14970324 15148649 15289873 18383874 17094418 18802399 17016601 17454858 16391804 20501625 16282729 16331619 18448328 18509181 17594712 16303861 18288408 17401013 18949393 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.28 | 17141729 14669216 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
9.28 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.76 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.76 | 14991402 16925845 8800419 17551590 9142499 10589399 9125849 9664655 9211117 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.76 | 8888407 17688650 16575769 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.27 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
11.27 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.81 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.06 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
12.06 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.06 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
12.06 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.06 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.05 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.05 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.20 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.11 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.17 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.95 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.94 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.59 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.31 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.08 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.45 | 16337965 16785472 16481741 17638652 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.84 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.84 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.09 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.09 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.09 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.92 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.14 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.66 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.01 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.87 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.80 | 18337622 15162350 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.80 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.19 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.54 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
20.88 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
20.88 | 16221962 19772884 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
20.88 | 15340226 16120746 12621046 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
20.88 | 15817613 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.21 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.58 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.91 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.64 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.90 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
6.90 | 12150543 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.86 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.78 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.95 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.95 | 15992940 17551590 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.49 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.49 | 16985049 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.77 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.70 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.89 | 16294345 17596541 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.89 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.15 | 17368321 17649720 16140955 17712046 15748426 17339181 17506722 17107899 12679006 9834237 17217047 16891316 16766008 16823087 19225113 19075265 16331271 19035177 19029980 17361223 16935935 16788101 17301526 17294898 19642359 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.31 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.40 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.40 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.40 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.38 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.38 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.11 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.29 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.34 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.81 | 15086387 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.44 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.19 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.63 | 18986760 16757204 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.03 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.40 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.40 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.75 | 18551238 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
10.75 | 18551238 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.26 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.26 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.26 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.54 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.54 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.31 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.31 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.44 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
9.23 | 14694615 17852074 12819281 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.35 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.90 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.34 | 15113037 16929163 19003803 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.34 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.53 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.53 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.42 | 18626508 19082440 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.61 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.57 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.81 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.01 | 18286688 18722050 16160472 15538739 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.89 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.89 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.95 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
9.95 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.95 | 1511512 17978042 14763951 11738929 3137016 15475178 11044598 16876388 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.56 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.56 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.78 | 19490988 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.21 | 15817613 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.57 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.51 | 17522103 19084572 16424979 19015929 17498489 15786421 16951190 18396642 18567086 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.51 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.03 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.84 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.84 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.26 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.23 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.54 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.29 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.33 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.46 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.46 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.64 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.07 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.97 | 16287080 |